Ghana: NO MO (NO MAS) Final Report

Ghana suffers from some of the most intense malaria transmission in sub-Saharan Africa. In 2010, a three-month field trial with 420 subjects was staged in Navrongo (northern Ghana), where NO MAS was tested for efficacy and product acceptance. In this study, a probability model was employed to estimate the product’s potential to reduce malaria infections.  Read PDF